Lead Product(s) : Undisclosed
Therapeutic Area : Nephrology
Study Phase : Undisclosed
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Collaboration
Details : AI-generated target was identified through Benevolent Platform® and AstraZeneca's scientific expertise and rich datasets. The Benevolent Platform® predicted this novel target, which was subsequently biologically validated through AstraZeneca's rigorous...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 27, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Nephrology
Highest Development Status : Undisclosed
Sponsor : AstraZeneca
Deal Size : Undisclosed
Deal Type : Collaboration